StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.67−0.10 (-12.58%)

Close on Nov 17, 2026Market cap $7.93MP/E –Yield –

Radiopharm Theranostics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -$52.78M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$52.78M–
FY2025Jun 30, 2025-$36.65M–
FY2024Jun 30, 2024-$22.98M–
FY2023Jun 30, 2023-$23.20M–

More Radiopharm Theranostics figures

See a number that looks wrong?